News
Amyloid transthyretin cardiomyopathy (ATTR-CM) is a progressive and life-threatening heart disease that can lead to increased ventricular wall thickness, restrictive cardiomyopathy, and heart failure.
The administration of ARGX-119 led to improved survival and muscle function in a passive transfer myasthenia gravis (MG) mice model, a study found.
New research shows the KIT p.D816V mutation is a significant predictor of adverse events during honeybee VIT and can predict VIT failure after wasp VIT.
Are you a healthcare provider looking for information on Diffuse Large B-Cell Lymphoma Epidemiology? Read about it here.
The relative apical sparing index (RASI) appears to accurately distinguish patients with AL-CM from those with ATTR-CM, a study found.
A new study found that a 4-week donidalorsen dosing regimen was superior to 8-week dosing in patients with hereditary angioedema (HAE).
The addition of a 4-biomarker panel to morphology significantly aids the classification of intrahepatic cholangiocarcinoma (iCCA) specimens.
Elafibranor seems to be slightly more effective than seladelpar as a second-line therapy in obtaining a biochemical response in patients with primary biliary cholnagitis (PBC), according to a systemic ...
Researchers presented the case of a patient with transthyretin-mediated amyloid cardiomyopathy (ATTR-CM) coexisting with RA.
Researchers have proposed a link between the availability of maternal-fetal medicine (MFM) physicians and decreased rates of maternal mortality.
A significant proportion of patients with B-cell ALL require third-line treatment, despite limited effective options.
Columnist with immune thrombocytopenia (ITP) gives tips for those recently diagnosed with the condition, including research and journaling.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results